Cumberland Pharmaceuticals Inc. Disposal Group, Including Discontinued Operation, Revenue
Cumberland Pharmaceuticals Inc. (CPIX) reported Disposal Group, Including Discontinued Operation, Revenue of -$8.63 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue · last filed 2026-08-07
- Cumberland Pharmaceuticals Inc. disposal group, including discontinued operation, revenue for the quarter ending 2026-06-30 was -$8.63M.
- Cumberland Pharmaceuticals Inc. disposal group, including discontinued operation, revenue for the quarter ending 2025-06-30 was -$10.46M.
- Cumberland Pharmaceuticals Inc. disposal group, including discontinued operation, revenue for fiscal 2020 was $3.21M, a 75.60% decline from fiscal 2019.
- Cumberland Pharmaceuticals Inc. disposal group, including discontinued operation, revenue for fiscal 2019 was $13.15M, a 15.34% increase from fiscal 2018.
- Cumberland Pharmaceuticals Inc. disposal group, including discontinued operation, revenue for fiscal 2018 was $11.40M.
| Period end | Disposal Group, Including Discontinued Operation, Revenue 3 month | Disposal Group, Including Discontinued Operation, Revenue 6 month | Disposal Group, Including Discontinued Operation, Revenue 12 month |
|---|---|---|---|
| 2026-06-30 | -$8.63M 10-Q · filed 2026-08-07 | -$17.60M 10-Q · filed 2026-08-07 | |
| 2025-06-30 | -$10.46M 10-Q · filed 2026-08-07 | -$22.00M 10-Q · filed 2026-08-07 | |
| 2020-12-31 | $3.21M 10-K · filed 2022-03-11 | ||
| 2019-12-31 | $13.15M 10-K · filed 2022-03-11 | ||
| 2018-12-31 | $11.40M 10-K · filed 2021-03-12 | ||
| 2017-12-31 | $14.83M 8-K · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |